Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: cisplatin|DRUG: everolimus|DRUG: paclitaxel|OTHER: laboratory biomarker analysis
Sponsor: Vanderbilt-Ingram Cancer Center
Collaborators: National Cancer Institute (NCI)